Moderately bullish activity in Pfizer (PFE), with shares up 10c, or 0.38%, near $25.39. Options volume roughly in line with average with 78k contracts traded and calls leading puts for a put/call ratio of 0.63, compared to a typical level near 0.58. Implied volatility (IV30) dropped 0.25 near 23.93,and below the 52wk median, suggesting an expected daily move of $0.38. Put-call skew flattened, suggesting a modestly bullish tone.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s Real‑World Breast Cancer Study Signals Strategic Push in HER2-Positive Market
- Madrigal Pharmaceuticals expands MASH pipeline with global license agreement
- LLY, JNJ, PFE: Big Pharma’s 2025 Comeback Is Bigger Than the Obesity Craze
- Pfizer’s Scottish RSV Maternal Vaccine Study: What Investors Should Watch
- Patent Cliff Overhang and Uncertain Pipeline Offset Obesity Upside, Justifying Hold on Fairly Valued Pfizer Shares